approved

Приложение 4 на ПЛС от 02.10.2019 г.

Unique identificator:  3a71363a-93ef-4673-a381-3b0cfaf07b86

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-10-03 09:13:02
  • Created by: georgi_sivchev
  • Updated at: 2019-10-03 09:13:02
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 789.12 157.82 946.94 4% 10 799.12 159.82 958.94 16% 25 824.12 164.82 988.94 НСР-5033/17.11.2014 01.12.2014 01.12.2014 Неактивен 3361
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 874.12 174.82 1048.94 4% 10 884.12 176.82 1060.94 16% 25 909.12 181.82 1090.94 Отхвърлена жалба от Комисия по прозрчаност с решение КП-260/18.12.2013 НСР-73/07.06.2013 16.03.2014 16.03.2014 Неактивен 3361
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 926.3 185.26 1111.56 4% 10 936.3 187.26 1123.56 16% 25 961.3 192.26 1153.56 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-397/07.01.2009 30.01.2009 30.01.2009 Неактивен 3361
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7900/25.01.2016. 09.02.2016 09.02.2016 Неактивен 3823
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-6072/23.04.2015. 08.05.2015 08.05.2015 Неактивен 3823
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7813/28.12.2015 13.01.2016 13.01.2016 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-5949/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1622.03 324.41 1946.44 4% 10 1632.03 326.41 1958.44 16% 25 1657.03 331.41 1988.44 НСР-3992/30.06.2014 15.07.2014 15.07.2014 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1739.08 347.82 2086.9 4% 10 1749.08 349.82 2098.9 16% 25 1774.08 354.82 2128.9 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; КЦРР-2426/22.02.2013 16.10.2013 16.10.2013 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1852.6 370.52 2223.12 4% 10 1862.6 372.52 2235.12 16% 25 1887.6 377.52 2265.12 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 19.12.2008 Неактивен 3736
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 14.14 2.83 16.97 6% 0.85 14.99 3 17.99 18% 2.55 17.54 3.51 21.05 Промяна на обстоятелства НСР-13979/25.09.2017; НСР-16103/13.07.2018 КЦРР-1094/26.07.2012; НСР-16104/13.07.2018 02.08.2018 02.08.2018 Активен 1310
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 Промяна на обстоятелства НСР-13979/25.09.2017 КЦРР-1094/26.07.2012 10.08.2012 02.11.2017 Неактивен 1310
Macrogol, combinations 5378/ 13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 КЦРР-1094/26.07.2012 10.08.2012 10.08.2012 Неактивен 1310
Macrogol, combinations 5378/13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 12.3 2.46 14.76 8% 0.98 13.28 2.66 15.94 20% 2.46 15.74 3.15 18.89 КЦ-1412/22.02.2010 10.03.2010 10.03.2010 Неактивен 1310
Cyclophosphamide 20020299 Endoxan, Powder for solution for injection, 500, mg, Pack: 1 Екофарм Груп АД, България Екофарм ЕООД, България 20.73 4.15 24.88 6% 1.24 21.97 4.39 26.36 18% 3.73 25.7 5.14 30.84 НСР-13864/14.09.2017 29.09.2017 02.10.2017 Активен 15853
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 08.03.2013 02.04.2018 Заличен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013 08.03.2013 02.10.2017 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Baxter Oncology GmbH - Germany 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017 КЦРР-2309/20.02.2013 08.03.2013 02.09.2017 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 КЦРР-2309/20.02.2013 08.03.2013 08.03.2013 Неактивен 1666
Cyclophosphamide II-1255/ 13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 42.19 8.44 50.63 4% 1.69 43.88 8.78 52.66 16% 6.75 50.63 10.13 60.76 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 3.77 0.75 4.52 7% 0.26 4.03 0.81 4.84 20% 0.75 4.78 0.96 5.74 Цената се вписва в регистъра на пределните цени с решение НСР-2722/06.02.2014 КЦРР-2309/20.02.2013 08.03.2013 08.03.2013 Заличен 1667
Cyclophosphamide II-1256/ 13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 4.19 0.84 5.03 7% 0.29 4.48 0.9 5.38 20% 0.84 5.32 1.06 6.38 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 1667
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.76 1.55 9.31 7% 0.54 8.3 1.66 9.96 20% 1.55 9.85 1.97 11.82 НСР-3198/07.04.2014; НСР-9769/14.07.2016 21.04.2014 02.08.2016 Заличен 2682
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.76 1.55 9.31 7% 0.54 8.3 1.66 9.96 20% 1.55 9.85 1.97 11.82 НСР-3198/07.04.2014 21.04.2014 21.04.2014 Неактивен 2682
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.94 1.59 9.53 7% 0.56 8.5 1.7 10.2 20% 1.59 10.09 2.02 12.11 КЦРР-1718/28.11.2012 г 01.01.2013 01.01.2013 Неактивен 2682
Showing 4426 to 4451 of 16075 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте